Su Golder
Associate Professor
Profile
Biography
Su is a an Associate Professor within the Health Services and Policy Research group in the Department of Health Sciences. She has a background as an information specialist with over 25 years' experience in literature searching. She has specialist expertise in systematic review methodology, systematic reviews of adverse effects and using social media as a data source. She has taught in these fields. Her PhD was funded by the MRC (Medical Research Council) and has made an important contribution to the retrieval of information on adverse effects both nationally and internationally. During her post-doctoral NIHR (National Institute for Health Research) fellowship she has expanded on her work in her PhD by investigating the use of unpublished data, text mining and social media in the retrieval of adverse effects data. In her current research she continues to undertake systematic reviews, develop systematic review methodology, conduct network analyses and to use social media to gain wider information as well as healthcare user and provider perspectives. She is currently an elective member of the Cochrane Methods Executive and one of the founders and co-convenors of the Cochrane Adverse Effects Methods Group.
Qualifications
- PhD, Department of Health Sciences, University of York
- MSc, Information School, University of Sheffield
- BSc (Hons), Department of Human and Health Sciences, University of Huddersfield
- FRSA
Departmental roles
- Member of Research Governance Committee
- Member of Departmental Library Committee
Research
Overview
Su's research interests include information retrieval, systematic reviews, methodology, unpublished and difficult to locate data, and adverse effects of healthcare interventions.
Projects
- Gonzalez G, Sarker A, Golder S, Rouhizadeh M, Klein AZ. 1st July 2018 to 30th June 2022 Social Media Mining for Pharmacovigilance. National Institutes for Health (NIH).
- Henschke N, Bergman H, Villanueva G, Morrison J, Loke Y, Golder S, Crosbie E, Kyrgiou M. Human papilloma virus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis and Population-level effects of Human papillomavirus (HPV) vaccination programmes on HPV-related disease and harms from vaccination Cochrane Evidence Synthesis Programme Grant ref. NIHR 1330406. 01/09/2021- 01/12/2022
- The Transformative Research on the Alcohol industry, Policy and Science (TRAPS) research progremme
- Partnership for REsponsive Policy Analysis and REsearch (PREPARE)
Past projects
- Gold Golder S. 2001 Evaluation and comparison of health technology assessment in Australia, New Zealand and the UK. Winston Churchill Fellowship
- Hempel S, Norman G, Golder S, Aguiar-Ibanez R, Eastwood A. 2006. Scoping review on the psychosocial interventions for carers of people with Parkinson’s Disease Parkinsons Disease Society (PDS)
- Golder S. 2007. Evaluating and optimising the retrieval of research evidence for systematic reviews of adverse effects. Funder: MRC Special Training Fellowship in Health Services Research and Health of the Public
- Stewart L, Golder S, Higgins J, Mannion R. 2012. Systematic review and meta-analysis of the safety and efficacy of recombinant human bone morphogenetic protein-2 (rhBMP-2) in spinal fusion. Yale University Open Data Access (YODA) initiative.
- Golder S. 2015. Using unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data. NIHR TCC: Post-Doctoral Fellowship.
- Higgins J, Reeves B, Sterne J, Savović J, Deeks J, Shepperd S, Waters E, Armstrong R, Waddington H, Golder S. 2015. Assessing risk of bias in non-randomized studies of interventions. Medical Research Council
- Jefferson T, Stewart L, Doshi P, Golder S, Boutron I, Lefebvre C, Heneghan C, Jones M. 2015 Interim guidance on the inclusion of clinical study reports and other regulatory documents in Cochrane Reviews. Cochrane Methods Innovation Fund (2) programme.
- Loke Y, Golder S, Vohra S. 2016 Development of guidance for the identification and quality assessment of adverse effects in systematic reviews. Cochrane Methods Innovation Fund (2) programme.
- Hill R, Maden M, Eldabe S, Khedmati Morasae E, Golder S, Williams N, Duarte R, Richardson M, Todd A, Smith C. NIHR128842 Safe and effective gradual reduction (tapering) of opioids in people with chronic non-cancer pain: systematic review of effects, barriers and facilitators and inequalities to inform service design in the NHS. Call: 18/145 HTA Pain Themed Call (Evidence Synthesis).
Research group(s)
Collaborators
External activities
Memberships
- Member of the SuRe (Summarized Research in Information Retrieval) Info project team
- Committee member of the PRISMA Harms Extension Steering Group
- Co-convenor of the Cochrane Adverse Effects Methods Group
- Member of the Cochrane Information Retrieval Methods Group Member of the InterTASC Information Specialists' Sub-Group (ISSG)
- Member of the European Association for Health Information and Libraries (EAHIL)
- Fellow of the Royal Society of Arts (RSA)
- Member of the Delphi forum committee for PRESS (Peer Review of Electronic Search Strategies)
Invited talks and conferences
- Golder S. Where to Identify Information on Adverse Effects for a Systematic Review – A Methodological Overview. Pharma-Bio-Med. Seville Spain, 7-11 November 2010.
- Golder S. Finding and Incorporating Information on Adverse Effects. Systematic Reviews Issues and Updates Symposium (Syrius II). ScHARR, Univerisity of Sheffield, Sheffield. 21 March 2011.
- Golder S. The Performance of Adverse Effects Search Filters in MEDLINE and EMBASE. Pharma-Bio-Med 2013. Berlin, Germany, 3-5 November 2013.
- Golder S. The contribution of different information sources for adverse effects data. Pharma-Bio-Med. Berlin, Germany, 3-5 November 2013.
- Golder S. The performance of adverse effects search filters in MEDLINE and EMBASE. Presented at the InterTASC Information Specialists' working group meeting. National Institute for Health and Care Excellence (NICE), Manchester, UK, 4 Dec 2013.
- Golder S. Data Sources and Search Strategies for Identifying Adverse Effects for Systematic Reviews. Cochrane UK and Ireland Annual Symposium. Manchester, UK, 23-24 April 2014.
- Golder S. Data sources and search strategies for adverse effects data. Medical Librarian Association (MLA) Conference. Chicago, U.S. 19 May 2014.
- Golder S. Systematic reviews: Where and how to search for information on adverse effects. Embase Webinar. 25 June 2014.
- Golder S. Where to find information on adverse drug effects. InterTASC Information Specialists' Sub-Group (ISSG) Workshop. Exeter, UK. 9 July 2014.
- Golder S. Rising above the noise: the benefits and pitfalls of searching social media for adverse effects. Pharma-Bio-Med & BioSciences Information Conference & Exposition. Rome, Italy, 26-28 October 2014.
- Golder S. Sometimes its Trickier than it looks! – Citation searching and some invaluable sources to improve your searching. Pharma-Bio-Med & BioSciences Information Conference & Exposition. Rome, Italy, 26-28 October 2014.
- Golder S, Norman G, Loke Y. Systematic review on social media as a data source for information on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
- Golder S, Junqueira D, Zorzela L. Adverse effects in systematic reviews: challenges for formulating the question and searching for different studies and sources of information. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
- Zorzela L, Golder S, Junqueira D. Reporting adverse events in reviews and the PRISMA Harms. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
- Junqueira D, Golder S, Zorzela L. Terminology challenges for data extraction and analysis of data on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
- Golder S. Social media and unpublished data as a source of information on adverse effects. Health Sciences Seminar, University of York, UK, 11 November 2015.
- Golder S. Norman G, Loke Y. Can social media help us find out about the side effects of treatments? NIHR Trainees Meeting. Leeds. 24-25 November 2015.
- Golder S. Social media and unpublished data as a source of information on adverse effects. Presented at the InterTASC Information Specialists' working group meeting. National Institute for Health and Care Excellence (NICE), Manchester, UK, 3 December 2015.
- Golder S, Norman G, Reed D. Ethics of social media research: A protocol for a systematic review. Conference: Ethics and Social Media Research By Academy of Social Sciences. London, 21 March 2016.
- Golder S. Does searching social media for adverse event data improve patient outcomes? Embase Webinar. 27 April 2016.
